Supplementary Figure 6: Histographic visualization of trogocytosis capability based on peptide dosing and variants. | Nature Methods

Supplementary Figure 6: Histographic visualization of trogocytosis capability based on peptide dosing and variants.

From: T cell antigen discovery via trogocytosis

Supplementary Figure 6

(a) Comparison of trogocytosis capability of murinized F5-Jurkat cells with A2-K562 cells loaded with different doses of cognate MART1 heteroclitic peptide (ELAGIGILTV). (b) Comparison of trogocytosis capability of murinized 1G4-Jurkat cells with A2-K562 cells loaded with different doses of cognate NYESO1 heteroclitic peptide (SLLMWITQV). (c) Comparison of trogocytosis capability of murinized F5-Jurkat cells with A2-K562 cells loaded with same dose of different MART1 peptide variants. (d) Comparison of trogocytosis capability of murinized 1G4-Jurkat cells with A2-K562 cells loaded with same dose of different NYESO1 peptide. Data are representative of two independent experiments.

Back to article page